Cartalax Peptide Vial
Stackpure provides Cartalax Peptide Vial for cartilage aging, osteoarthritis modelling, and joint tissue repair research. This research-grade peptide vial is a tetrapeptide bioregulator (Ala-Glu-Asp-Leu) developed to restore normal transcription in cartilage cells, supporting proteoglycan synthesis and chondrocyte function. Produced to +99% purity (HPLC verified), cGMP-certified, with a Certificate of Analysis available every batch.
For in vitro research use only. Not for human consumption. Not approved by the FDA. Not a drug, medicine, or supplement.
Your batch's actual Certificate of Analysis is available on request with your order and batch number, usually within 24 hours. Full testing standards on the Lab Testing page.
Cartalax Peptide Vial is a research-grade peptide vial supplied by Stackpure for laboratory investigation. Cartalax is studied in the context of tissue repair, wound healing, and musculoskeletal recovery. Each unit is manufactured in a cGMP-certified facility and verified to +99% purity by HPLC analysis before dispatch.
What Is Cartalax?
Cartalax is a compound that has attracted significant interest in preclinical research examining tissue repair, wound healing, and musculoskeletal recovery. Scientists investigating Cartalax have worked to characterise its mechanisms, receptor interactions, and downstream biological effects across multiple in vitro and animal model systems.
Stackpure provides Cartalax Peptide Vial for researchers requiring verified, traceable material. Supplied as a lyophilised powder vial, this format offers maximum stability and flexibility for laboratory reconstitution. Explore the full Stackpure catalogue for additional Cartalax research formats.
this peptide vial Research Applications
Preclinical studies involving this peptide vial have explored the following areas:
- Tissue regeneration: Studies have examined the role of this compound in accelerating repair of damaged connective tissue, tendons, and ligaments.
- Wound healing: Preclinical models have investigated angiogenic and fibroblast-stimulating properties relevant to dermal and mucosal wound repair.
- Musculoskeletal support: Research has explored protective and regenerative effects on muscle, bone, and cartilage under injury conditions.
These directions reflect the broad scientific interest in Cartalax and the growing body of literature examining its potential applications in research contexts.
Stackpure's peptide vial Quality Standards
Every this peptide vial supplied by Stackpure is held to rigorous analytical standards. Researchers choosing Stackpure peptide vial receive material that has been independently verified for identity, purity, and potency. Quality documentation includes a Certificate of Analysis (COA) for every production batch, providing full analytical transparency.
- Purity: +99% by HPLC analysis
- Facility: cGMP-certified manufacturing
- Testing: Identity, purity, and potency verified per batch
- Documentation: COA available for every order
This analytical rigour ensures that researchers working with Stackpure's peptide vial can maintain experimental consistency and reproducibility across studies.
Research Use Disclaimer
Independent Lab Verification
Stackpure works with independent, accredited third-party laboratories, including Vanguard Laboratory (ISO 17025:2017-accredited, A2LA Certificate #6377.01.01), to verify compound identity and purity. A Certificate of Analysis is included with every order.
this peptide vial from Stackpure is supplied strictly for in vitro research and laboratory purposes. This material is not approved for human or veterinary use and is not intended to diagnose, treat, cure, or prevent any condition. All research involving this peptide vial must be conducted in accordance with applicable institutional, ethical, and regulatory guidelines. For research use only.
Working with the lyophilized vial
- Supplied as a freeze-dried powder, which keeps the compound stable until it is needed.
- Requires reconstitution with a suitable diluent such as bacteriostatic water before use in a protocol.
- Unopened vials are kept cold and away from light. Once reconstituted, solutions are kept refrigerated and used within the window set by your protocol.
- Reconstituted concentration depends on the diluent volume you choose, so the same vial supports different working concentrations.
Research Questions
What is Cartalax Peptide Vial used for in research?
this peptide vial is a research-grade peptide vial studied for cartilage aging, osteoarthritis modelling, and joint tissue repair research. It acts as a tetrapeptide bioregulator (Ala-Glu-Asp-Leu) developed to restore normal transcription in cartilage cells, supporting proteoglycan synthesis and chondrocyte function. All findings are from pre-clinical in vitro and animal studies; it is not approved for human use.
How does Cartalax Peptide Vial work?
this peptide vial is a tetrapeptide bioregulator (Ala-Glu-Asp-Leu) developed to restore normal transcription in cartilage cells, supporting proteoglycan synthesis and chondrocyte function. This mechanism has been characterised in multiple pre-clinical studies, with particular focus on cartilage aging outcomes.
What research dosage is used for Cartalax Peptide Vial?
Bioregulator protocols from the Russian Institute of Bioregulation typically used 10 mg/day for 10–20 days. All dosage information is from pre-clinical or research contexts only. this peptide vial is sold exclusively for research use and is not approved for human consumption.
How does Cartalax Peptide Vial compare to related research compounds?
this peptide vial is frequently studied alongside Bronchogen and Thymalin within the Khavinson bioregulator framework. Its cartilage bioregulator classification distinguishes its mechanism from these alternatives, making it suitable for pathway-specific research protocols.
Where can I buy Cartalax Peptide Vial for research purposes?
Stackpure supplies this peptide vial as a research-grade peptide vial with +99% purity (HPLC verified), cGMP certification, and a Certificate of Analysis. Orders ship to the US, UK, Canada, and Australia. It is sold for in vitro research use only.
What does the Certificate of Analysis verify for Cartalax Peptide Vial?
A Certificate of Analysis (COA) reports identity (confirming the compound is what it's labeled as, via HPLC-UV/VIS matched against a reference standard) and assay/content (the measured purity percentage). this peptide vial is tested through independent third-party laboratory analysis, including work performed by Vanguard Laboratory (ISO 17025:2017-accredited, A2LA Certificate #6377.01.01), which is what verifies a batch matches its labeled specification rather than relying on a purity claim alone.